A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
This study is currently recruiting participants.
Verified March 2013 by Therapeutic Advances in Childhood Leukemia Consortium
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Collaborator:
Novartis
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium
ClinicalTrials.gov Identifier:
NCT01321346
First received: March 21, 2011
Last updated: March 11, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |